Company Filing History:
1 out of 77 
1 out of 9 Years Active: 2021
Title: Masaaki Toyama: Innovator in Antiviral Drug Development
Introduction
Masaaki Toyama is a notable inventor based in Kagoshima, Japan. He has made significant contributions to the field of antiviral drug development, particularly in addressing severe fever with thrombocytopenia syndrome. His innovative work has led to the creation of a unique antiviral drug that holds promise for treating this serious condition.
Latest Patents
Masaaki Toyama holds 1 patent for an antiviral drug specifically designed for severe fever with thrombocytopenia syndrome. The invention involves a compound represented by a specific formula, which includes a salt or solvate of the compound. The formula details that R1 and R2 can be either the same or different, representing substituted or unsubstituted C1-10 alkyl groups. Additionally, R1 and R2 may form a substituted or unsubstituted 5- or 6-member ring in conjunction with an adjacent nitrogen atom, while X represents a halogen atom.
Career Highlights
Throughout his career, Masaaki Toyama has been associated with prominent institutions such as Kagoshima University and Nobelpharma Co., Ltd. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Masaaki Toyama has collaborated with esteemed colleagues, including Masanori Baba and Norikazu Sakakibara. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in the field of antiviral drugs.
Conclusion
Masaaki Toyama's contributions to antiviral drug development exemplify the impact of dedicated research and innovation. His work not only addresses critical health issues but also showcases the importance of collaboration in scientific advancements.